Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Top 10 Selling Medicines January -February 2017 Price Movement. Ex-Factory, Wholesale And Retail Price Index.

|Includes: ACAD, Inovio Pharmaceuticals, Inc. (INO)

Biggest mover (Humira): Adalimumab. Ex-factory +6%. Wholesale +6% Retail +8%

Biggest mover (Humira): Adalimumab. Ex-factory +6%. Wholesale +6% Retail +8%

Beginning January 2017, each month, Pharma14 will list a European average of the official ex-factory, wholesale and retail prices of the top 10 selling drugs. To keep the prices here as accurate as possible over 800 points of data were sampled to reach the averages in the tables below. All 30 countries sampled were given equal weight in the averages and no preference was given to larger markets.

February saw little movement besides Adalimumab (Humira) that recorder an increase of 6% in the ex-factory and wholesale averages and an 8% increase in the average retail prices.

Average European prices for top ten selling for Feb. 1 2017.

The data compiled for this index is based on the official prices across 30 European markets*.

Adalimumab 40 mg/0.8ml 0.8 ml

Average European Feb. 2017 ex-factory price: EUR 552.70

Average European Feb. 2017 wholesale price: EUR 574.83

Average European Feb. 2017 retail price: EUR 664.65

Ledipasvir/Sofosbuv 90 mg 28 Tablets

Average European Feb. 2017 ex-factory price: EUR 15,972.37

Average European Feb. 2017 wholesale price: EUR 16,679.48

Average European Feb. 2017 retail price: EUR 18,656.94

Etanercept 50 mg/ml Per unit

Average European Feb. 2017 ex-factory price: EUR 233.71

Average European Feb. 2017 wholesale price: EUR 243.57

Average European Feb. 2017 retail price: EUR 282.99

Infliximab 100 mg. Per single unit

Average European Feb. 2017 ex-factory price: EUR 417.37

Average European Feb. 2017 wholesale price: EUR 436.90

Average European Feb. 2017 retail price: EUR 508.68

Rituximab 500 mg. Per 50 ml unit

Average European Feb. 2017 ex-factory price: EUR 1,224.73

Average European Feb. 2017 wholesale price: EUR 1,280.66

Average European Feb. 2017 retail price: EUR 1,479.13

Insulin Glargine 100 i.u./ml Per 3 ml unit

Average European Feb. 2017 ex-factory price: EUR 9.26

Average European Feb. 2017 wholesale price: EUR 9.77

Average European Feb. 2017 retail price: EUR 12.50

Bevacizumab 25 mg/ml 4 ml

Average European Feb. 2017 ex-factory price: EUR 294.86

Average European Feb. 2017 wholesale price: EUR 313.06

Average European Feb. 2017 retail price: EUR 362.44

Trastuzumab 150 mg powder for infusion Single unit

Average European Feb. 2017 ex-factory price: EUR 551.70

Average European Feb. 2017 wholesale price: EUR 577.38

Average European Feb. 2017 retail price: EUR 662.31

Lenalidomide 10 mg 21 Capsules

Average European Feb. 2017 ex-factory price: EUR 4,771.77

Average European Feb. 2017 wholesale price: EUR 5,027.91

Average European Feb. 2017 retail price: EUR 5,578.13

Sofosbuvir 400 mg 28 Tablets

Average European Feb. 2017 ex-factory price: EUR 13,760.60

Average European Feb. 2017 wholesale price: EUR 14,417.96

Average European Feb. 2017 retail price: EUR 16,360.71

About Pharma14.com

Pharma14.com is a global Marketing Authorization medicine data base and medicine price index. Members can access and search 750,000 Marketing Authorizations across 37 markets and 300,000 drug prices from 35 markets. All our databases are updated monthly and we are adding new data from new countries monthly. Additionally members can upload their medicines and post medicine buy requests in our marketplace section. For further details please visit pharma14.com or email us directly at info@pharma14.com.

We are currently seeking partners and affiliates to promote pharma14 to the pharmaceutical industry with high very commissions.

* Data based on official pricing from following countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Slovakia, Spain, Sweden, Switzerland, United Kingdom.

Supporting Documents

  1. feb_med_list.jpg